Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cidofovir for Peripheral CMV Retinitis
NCT00004794Phase 2Completed
- Sponsor
- National Center for Research Resources
- Start
- Mar 1995
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of cidofovir in cytomegalovirus retinitis (3 arms), sponsored by National Center for Research Resources. Primary endpoint: Time to progression of retinitis at 23 weeks. Started Mar 1995; status: completed.
02
Drugs
cidofovir
03
Conditions
cytomegalovirus retinitis
Beyond the preview
Go deeper on NCT00004794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004794.